INTENSIVE CARE MEDICINE / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Chronic obstructive pulmonary disease (COPD) has shown a rising trend in morbidity and mortality over the years, leading to a growing economic burden globally. The aim of this study was to establish a predictive score for assessing the risk of death in patients with severe acute exacerbations of COPD (AECOPD) to help clinicians evaluate the condition and prognosis of patients.

Material and methods:
Patients hospitalized for severe AECOPD were consecutively included. All patients were randomly assigned to the developmental and validation cohorts in a 7 : 3 ratio. We identified independent prognostic factors for in-hospital mortality in the development cohort by univariate analysis and multivariate logistic regression analysis. In the validation cohort, the predictive power of the new score was verified and compared to the other four scores.

Results:
A total of 488 patients with severe AECOPD who were hospitalized between January 2011 and October 2022 were included. The mean age was 78.0 ±8.2 years and 361 (74.0%) of the patients were male. The development cohort included 342 patients, 40 of whom died during hospitalization. The five independent risk factors associated with in-hospital mortality according to multi-factorial regression analysis were white blood cell count (WBC) > 10 × 109/l, lymphocyte count < 0.8 × 109/l, age > 80 years, confusion, and chronic heart failure. In the validation cohort, the new prediction score had good predictive power (AUC = 0.826, 95% CI: 0.724–0.928) and performed more strongly than other clinical prediction scores.

Conclusions:
The new predictive score is a simple and effective way to predict mortality in hospitalized patients with severe AECOPD.

 
REFERENCES (31)
1.
Hess MW. The 2017 Global Initiative for Chronic obstructive lung disease report and practice implications for the respiratory therapist. Respir Care 2017; 62: 1492-500.
 
2.
Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J 2019; 53: 1900164.
 
3.
Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017; 5: 691-706.
 
4.
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018; 391: 1706-17.
 
5.
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-60.
 
6.
Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012; 67: 970-6.
 
7.
Lim SW, der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82.
 
8.
Ying PT, Xiaowu S, Johannes RS, Vikas G, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med 2009; 169: 1595-602.
 
9.
Memon MA, Faryal S, Brohi N, Kumar B. Role of the DECAF score in predicting in-hospital mortality in acute exacerbation of chronic obstructive pulmonary disease. Cureus 2019; 11: e4826.
 
10.
Echevarria C, Steer J, Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax 2016; 71: 133-40.
 
11.
Sangwan V, Chaudhry D, Malik R. Dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score and BAP-65 score, tools for prediction of mortality in acute exacerbations of chronic obstructive pulmonary disease: a comparative pilot study. Indian J Crit Care Med 2017; 21: 671-7.
 
12.
Ji Z, Li X, Lei S, Xu J, Xie Y. A pooled analysis of the risk prediction models for mortality in acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J 2023; 17: 707-18.
 
13.
Zhang J, Yi Q, Zhou C, et al. A simple clinical risk score (ABCDMP) for predicting mortality in patients with AECOPD and cardiovascular diseases. Respir Res 2024; 25: 89.
 
14.
Waeijen-Smit K, Crutsen M, Keene S, et al. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients. ERJ Open Res 2024; 10:00838-2023.
 
15.
Huang Q, He C, Xiong H, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 2020; 10: e037923.
 
16.
Cho SJ, Stout-Delgado HW. Aging and lung disease. Annu Rev Physiol 2020; 82: 433-59.
 
17.
Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957-63.
 
18.
Peng L, Zhou C, Zhou H, et al. Risk factors associated with in-hospital mortality in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a multicenter retrospective study. Zhonghua Yi Xue Za Zhi 2021; 101: 3932-7.
 
19.
Crisafulli E, Manco A, Guerrero M, et al. Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD. Intern Emerg Med 2021; 16: 401-8.
 
20.
Messer B, Griffiths J, Baudouin SV. The prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review. QJM 2012; 105: 115-26.
 
21.
Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10: 81-9.
 
22.
Cao Y, Xing Z, Long H, et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respir Res 2021; 22: 77.
 
23.
Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-26.
 
24.
D’Anna SE, Maniscalco M, Cappello F, et al. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease. Ann Med 2021; 53: 135-50.
 
25.
Domenico A, Pietro S, Mauro C, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med 2018; 18: 116.
 
26.
Moberg M, Vestbo J, Martinez G, Lange P, Ringbaek T. Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease. ScientificWorldJournal 2014; 2014: 140736.
 
27.
Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 2285-90.
 
28.
Smith BM, Kawut SM, Bluemke DA, et al. Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation 2013; 127: 1503-11, 11e1-6.
 
29.
Smith BM, Prince MR, Hoffman EA, et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. Chest 2013; 144: 1143-51.
 
30.
Axson EL, Ragutheeswaran K, Sundaram V, et al. Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis. Respir Res 2020; 21: 54.
 
31.
Zhang Y, Lin YX. Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2019; 42: 895-900.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top